Clinical Trials
3 trialsNCT06917313 2026-06-02
FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
Yale University
Phase 2 Recruiting
NCT06617455 2026-05-06
VEnT
University of Michigan Rogel Cancer Center
Phase 2 Terminated
NCT07568236 2026-05-05
A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT)
Chinese University of Hong Kong
Phase 2 Not yet recruiting